{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:11:22Z","timestamp":1790626282120,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Therapeutic drug monitoring to optimize drug therapy typically relies on the inconvenience of repeated plasma sampling. Sweat is a potential alternative biofluid convenient for sampling. However, limited information exists regarding the range of drugs excreted in sweat and their correlation with plasma concentrations. This study evaluated drugs in sweat and plasma of an ambulatory clinical cohort. Pilocarpine-induced sweat was collected from ambulatory participants at a single instance using an absorbent nylon mesh, followed by concurrent blood sampling for ratio and correlation analyses. In a model drug study, the pharmacokinetics of acetaminophen in sweat and plasma were compared. Of the 14 drugs and 2 metabolites monitored in the clinical study, all compounds were present in sweat and plasma; however, the sweat-to-plasma ratio varied substantially across the drugs. Opioids and methocarbamol demonstrated the highest concentrations in sweat, sometimes exceeding plasma concentrations. Selected antidepressants and muscle relaxants were also detected in sweat at a 2\u201310-fold dilution to the plasma. Others, such as gabapentin and pregabalin, were highly diluted (&gt;30-fold) in sweat compared with plasma. Together, these data suggest that molecular attributes, specifically hydrophobicity (logP) and charge state at physiologic pH (7.4), enable reasonable prediction of sweat-to-plasma drug correlation. These findings demonstrated that sweat could be used as an alternative biofluid for therapeutic drug monitoring. The findings also suggest that although it has been broadly accepted that small hydrophobic molecules most likely have a strong plasma correlation, there is a small window of hydrophobicity and charge state that permits sweat partitioning.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001110","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T04:10:49Z","timestamp":1685506249000},"page":"731-742","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Diverse Drug Classes Partition into Human Sweat: Implications for Both Sweat Fundamentals and for Therapeutic Drug Monitoring"],"prefix":"10.1097","volume":"45","author":[{"given":"Theresa","family":"Ruwe","sequence":"first","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evyn","family":"White","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan S.","family":"Zebertavage","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Runnoe","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Fay","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Daumeyer","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Tracy","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"},{"name":"Tracy Consultants, Huntsville, Alabama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara Fay","family":"Uchtman","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavi","family":"Begtrup","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Baltimore, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Heikenfeld","sequence":"additional","affiliation":[{"name":"Novel Device Laboratory, Biomedical Engineering Department, University of Cincinnati, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Buggele","sequence":"additional","affiliation":[{"name":"Eccrine Systems, Inc., Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J Intern Med."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2017.03.052","article-title":"The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines","volume":"217","author":"Malhi","year":"2017","journal-title":"J Affect Disord."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/00912700122010429","article-title":"Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients","volume":"41","author":"Venkataramanan","year":"2001","journal-title":"J Clin Pharmacol."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00007691-198512000-00003","article-title":"New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics","volume":"7","author":"Wagner","year":"1985","journal-title":"Ther Drug Monit."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jsat.2006.11.008","article-title":"Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing","volume":"33","author":"Jaffee","year":"2007","journal-title":"J Substance Abuse Treat."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/clpt.1984.151","article-title":"Relationship between caffeine concentrations in plasma and saliva","volume":"36","author":"Zylber-Katz","year":"1984","journal-title":"Clin Pharmacol Ther."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/adc.56.8.637","article-title":"Saliva carbamazepine and phenytoin level monitoring","volume":"56","author":"Rylance","year":"1981","journal-title":"Arch Dis Child."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jat\/bkv087","article-title":"A dilute-and-shoot LC-MS method for quantitating opioids in oral fluid","volume":"39","author":"Enders","year":"2015","journal-title":"J Anal Toxicol."},{"key":"R10-20250603","first-page":"147","article-title":"Drug testing in oral fluid","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs' plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov Today"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-4347(99)00246-7","article-title":"Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry","volume":"733","author":"Huestis","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jat\/24.7.509","article-title":"Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing","volume":"24","author":"Huestis","year":"2000","journal-title":"J Anal Toxicol."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/FTD.0b013e3181c13aaf","article-title":"Monitoring pregnant women's illicit opiate and cocaine use with sweat testing","volume":"32","author":"Brunet","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00216-008-2228-0","article-title":"Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat","volume":"392","author":"Brunet","year":"2008","journal-title":"Anal Bioanal Chem."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00216-010-4392-2","article-title":"Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry","volume":"400","author":"Concheiro","year":"2011","journal-title":"Anal Bioanal Chem."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1373\/clinchem.2008.117093","article-title":"Disposition of MDMA and metabolites in human sweat following controlled MDMA administration","volume":"55","author":"Barnes","year":"2009","journal-title":"Clin Chem."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jat\/25.2.144","article-title":"Sweat testing of MDMA with the Drugwipe(R) analytical device: a controlled study with two volunteers","volume":"25","author":"Pacifici","year":"2001","journal-title":"J Anal Toxicol."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.forsciint.2007.04.002","article-title":"Excretion of \u03949-tetrahydrocannabinol in sweat","volume":"174","author":"Huestis","year":"2008","journal-title":"Forensic Sci Int."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/FTD.0000000000000327","article-title":"Cannabis use surveillance by sweat analysis","volume":"38","author":"Gambelunghe","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2230.1993.tb00987.x","article-title":"Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat","volume":"18","author":"Faergemann","year":"1993","journal-title":"Clin Exp Dermatol."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0190-9622(99)70393-2","article-title":"Pharmacokinetics of fluconazole in skin and nails","volume":"40","author":"Faergemann","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1439-0507.1994.tb00788.x","article-title":"Bioavailability of fluconazole in the skin after oral medication","volume":"37","author":"Wildfeuer","year":"2009","journal-title":"Mycoses"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.24.6.876","article-title":"Orally administered ketoconazole: route of delivery to the human stratum corneum","volume":"24","author":"Harris","year":"1983","journal-title":"Antimicrob Agents Chemother."},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0190-9622(88)70037-7","article-title":"Pharmacokinetic profile of orally administered itraconazole in human skin","volume":"18","author":"Cauwenbergh","year":"1988","journal-title":"J Am Acad Dermatol."},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/anatox\/35.8.558","article-title":"Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient","volume":"35","author":"Lankheet","year":"2011","journal-title":"J Anal Toxicol."},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/1078155218769136","article-title":"Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy","volume":"25","author":"Irie","year":"2019","journal-title":"J Oncol Pharm Pract."},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(96)09229-X","article-title":"Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis","volume":"349","author":"H\u00f8iby","year":"1997","journal-title":"Lancet"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.44.10.2855-2857.2000","article-title":"Excretion of beta-lactam antibiotics in sweat\u2014a neglected mechanism for development of antibiotic resistance?","volume":"44","author":"H\u00f8iby","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1373\/clinchem.2006.067983","article-title":"Opioid disposition in human sweat after controlled oral codeine administration","volume":"52","author":"Schwilke","year":"2006","journal-title":"Clin Chem."},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jsat.2007.03.004","article-title":"Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence","volume":"33","author":"Chawarski","year":"2007","journal-title":"J Substance Abuse Treat."},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","article-title":"BDDCS, the rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv Drug Deliv Rev."},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1523-1747.ep12260784","article-title":"Drug excretion in human eccrine sweat","volume":"56","author":"Johnson","year":"1971","journal-title":"J Invest Dermatol."},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/164974","article-title":"Recent developments in sweat analysis and its applications","volume":"2015","author":"Jadoon","year":"2015","journal-title":"Int J Anal Chem."},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40262-017-0626-1","article-title":"Tacrolimus concentration in saliva of kidney transplant recipients: factors influencing the relationship with whole blood concentrations","volume":"57","author":"Ghareeb","year":"2018","journal-title":"Clin Pharmacokinet."},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci Int."},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"53553","DOI":"10.1021\/acsami.1c14175","article-title":"Oil-membrane protection of electrochemical sensors for fouling- and pH-insensitive detection of lipophilic analytes","volume":"13","author":"Yuan","year":"2021","journal-title":"ACS Appl Mater Inter."},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"031301","DOI":"10.1063\/1.4921039","article-title":"The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications","volume":"9","author":"Sonner","year":"2015","journal-title":"Biomicrofluidics"},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41587-019-0040-3","article-title":"Accessing analytes in biofluids for peripheral biochemical monitoring","volume":"37","author":"Heikenfeld","year":"2019","journal-title":"Nat Biotechnol."},{"key":"R43-20250603","first-page":"348","article-title":"Exploring QSAR: hydrophobic, electronic, and steric constants","volume":"39","author":"Martin","year":"1995","journal-title":"J Chem"},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/bk-1995-0606.ch019","article-title":"Comparative QSAR: understanding hydrophobic interactions","volume":"606","author":"Hansch","year":"1995","journal-title":"ACS Symp Ser."},{"key":"R45-20250603","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet."},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1011954332221","article-title":"pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs","volume":"15","author":"Avdeef","year":"1998","journal-title":"Pharm Res."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:13:06Z","timestamp":1748970786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001110","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"2023-01-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}